Evidence map›Paper›PMID 42125603›Full record

ArticleClinical and translational radiation oncology2026

A pilot study of [

Bradley Eckelmann, Takwa Salem, April Premo, Kaili Ranta, Colin Harari, Benjamin Durkee, Matthew Larson, Azam Ahmed, Ali Pirasteh, Michael C Veronesi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bradley EckelmannDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Takwa SalemSchool of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
April PremoDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Kaili RantaDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Colin HarariDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Benjamin DurkeeDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Matthew LarsonDepartment of Radiology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Azam AhmedDepartment of Neurosurgery, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Ali PirastehDepartment of Radiology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Michael C VeronesiDepartment of Radiology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.
Brett MorrisDepartment of Human Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Radiation treatment planning for pituitary tumors traditionally involves magnetic resonance imaging (MRI) imaging. However, the gross tumor volume (GTV) may be difficult to delineate for patients after resection and recurrence. Advanced positron emission tomography (PET) imaging using [ Methods and materials: This IRB-approved protocol retrospectively contoured GTVs for seven patients who had undergone [ Results: The median MRI volume for each physician ranged from 4.41 to 7.19 cm Conclusions: These results support the conclusion that [

Indexed as

DOTATATEPituitaryRadiationRadiotherapy

Identifiers

PMID42125603
PMCPMC13158614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.